Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer47
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer46
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review30
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis27
Overexpression of CAD in stomach adenocarcinoma tissues and its clinical significance20
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance18
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer17
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics17
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment17
Psoas muscle depletion correlates with poor prognosis and compromised immunity in resectable gastric cancer: A multicenter study16
Table of Contents16
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations16
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans14
Editorial Board13
0.15811800956726